Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Notes Payables (2017 - 2025)

HealthLynked (HLYK) has disclosed Notes Payables for 9 consecutive years, with $293937.0 as the latest value for Q3 2025.

  • On a quarterly basis, Notes Payables rose 47.6% to $293937.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $293937.0, a 47.6% increase, with the full-year FY2024 number at $127095.0, down 78.25% from a year prior.
  • Notes Payables was $293937.0 for Q3 2025 at HealthLynked, up from $291788.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $724950.0 in Q1 2023 to a low of $7343.0 in Q3 2022.
  • A 5-year average of $320691.9 and a median of $313758.0 in 2021 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: skyrocketed 4352.08% in 2023, then plummeted 78.25% in 2024.
  • HealthLynked's Notes Payables stood at $300600.0 in 2021, then decreased by 2.98% to $291650.0 in 2022, then soared by 100.35% to $584323.0 in 2023, then tumbled by 78.25% to $127095.0 in 2024, then soared by 131.27% to $293937.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Notes Payables are $293937.0 (Q3 2025), $291788.0 (Q2 2025), and $329342.0 (Q1 2025).